Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 238

1.

Ciprofloxacin as antipseudomonal treatment in patients with cystic fibrosis.

Schaad UB, Wedgwood J, Ruedeberg A, Kraemer R, Hampel B.

Pediatr Infect Dis J. 1997 Jan;16(1):106-11; discussion 123-6.

PMID:
9002119
2.

Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations. The Cystic Fibrosis Study Group.

Church DA, Kanga JF, Kuhn RJ, Rubio TT, Spohn WA, Stevens JC, Painter BG, Thurberg BE, Haverstock DC, Perroncel RY, Echols RM.

Pediatr Infect Dis J. 1997 Jan;16(1):97-105; discussion 123-6.

PMID:
9002118
3.

Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.

Cantón R, Cobos N, de Gracia J, Baquero F, Honorato J, Gartner S, Alvarez A, Salcedo A, Oliver A, García-Quetglas E; Spanish Consensus Group for Antimicrobial Therapy in the Cystic Fibrosis Patient.

Clin Microbiol Infect. 2005 Sep;11(9):690-703. Review.

4.

Efficacy of inhaled amikacin as adjunct to intravenous combination therapy (ceftazidime and amikacin) in cystic fibrosis.

Schaad UB, Wedgwood-Krucko J, Suter S, Kraemer R.

J Pediatr. 1987 Oct;111(4):599-605.

PMID:
3309236
5.

A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.

Metallidis S, Kollaras P, Giannakakis T, Seitanidis B, Kordosis T, Nikolaidis J, Hatzitolios A, Nikolaidis P.

Eur J Intern Med. 2008 Dec;19(8):619-24. doi: 10.1016/j.ejim.2007.08.011. Epub 2008 Apr 29.

PMID:
19046729
6.

Ciprofloxacin therapy in cystic fibrosis.

Scully BE, Nakatomi M, Ores C, Davidson S, Neu HC.

Am J Med. 1987 Apr 27;82(4A):196-201.

PMID:
3555036
7.

The efficacy and safety of ciprofloxacin and ofloxacin in chronic Pseudomonas aeruginosa infection in cystic fibrosis.

Jensen T, Pedersen SS, Nielsen CH, Høiby N, Koch C.

J Antimicrob Chemother. 1987 Oct;20(4):585-94.

PMID:
3479420
8.

Pharmacokinetic disposition of sequential intravenous/oral ciprofloxacin in pediatric cystic fibrosis patients with acute pulmonary exacerbation.

Rubio TT, Miles MV, Lettieri JT, Kuhn RJ, Echols RM, Church DA.

Pediatr Infect Dis J. 1997 Jan;16(1):112-7; discussion 123-6.

PMID:
9002120
9.

Monotherapy with intravenous followed by oral high-dose ciprofloxacin versus combination therapy with ceftazidime plus amikacin as initial empiric therapy for granulocytopenic patients with fever.

Giamarellou H, Bassaris HP, Petrikkos G, Busch W, Voulgarelis M, Antoniadou A, Grouzi E, Zoumbos N.

Antimicrob Agents Chemother. 2000 Dec;44(12):3264-71.

10.

Antipseudomonal therapy in cystic fibrosis: aztreonam and amikacin versus ceftazidime and amikacin administered intravenously followed by oral ciprofloxacin.

Schaad UB, Wedgwood-Krucko J, Guenin K, Buehlmann U, Kraemer R.

Eur J Clin Microbiol Infect Dis. 1989 Oct;8(10):858-65.

PMID:
2512129
11.

Ciprofloxacin monotherapy for acute pulmonary exacerbations of cystic fibrosis.

Goldfarb J, Stern RC, Reed MD, Yamashita TS, Myers CM, Blumer JL.

Am J Med. 1987 Apr 27;82(4A):174-9.

PMID:
3555032
12.

Intravenous and oral mono- or combination-therapy in the treatment of severe infections: ciprofloxacin versus standard antibiotic therapy. Ciprofloxacin Study Group.

Krumpe PE, Cohn S, Garreltes J, Ramirez J, Coulter H, Haverstock D, Echols R.

J Antimicrob Chemother. 1999 Mar;43 Suppl A:117-28.

PMID:
10225582
13.

Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosis.

Conway SP, Pond MN, Watson A, Etherington C, Robey HL, Goldman MH.

Thorax. 1997 Nov;52(11):987-93.

14.

Ciprofloxacin in the treatment of Pseudomonas infection in cystic fibrosis patients.

Rubio TT, Shapiro C.

J Antimicrob Chemother. 1986 Nov;18 Suppl D:147-52.

PMID:
3100490
16.

Randomized study of two dosage regimens of ciprofloxacin for treating chronic bronchopulmonary infection in patients with cystic fibrosis.

Shalit I, Stutman HR, Marks MI, Chartrand SA, Hilman BC.

Am J Med. 1987 Apr 27;82(4A):189-95.

PMID:
3555035
18.

Eradication of initial Pseudomonas aeruginosa colonization in patients with cystic fibrosis.

Griese M, Müller I, Reinhardt D.

Eur J Med Res. 2002 Feb 21;7(2):79-80.

PMID:
11891148
19.

Are antipseudomonal antibiotics really beneficial in acute respiratory exacerbations of cystic fibrosis?

Wolter JM, Bowler SD, McCormack JG.

Aust N Z J Med. 1999 Feb;29(1):15-21.

PMID:
10200808
20.

Molecular epidemiological analysis of Pseudomonas aeruginosa strains causing failure of antibiotic therapy in cystic fibrosis patients.

Bingen E, Denamur E, Picard B, Goullet P, Lambert-Zechovsky N, Foucaud P, Navarro J, Elion J.

Eur J Clin Microbiol Infect Dis. 1992 May;11(5):432-7.

PMID:
1358612

Supplemental Content

Support Center